Entry Point Capital, LLC ENLIVEN THERAPEUTICS INC Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Number of Shares
241
Previous 9,510
97.47%
Holding current value
$5.63 Million
Previous $167 Million
96.63%
% of portfolio
0.01%
Previous 0.15%